GT Biopharma (GTBP) SEC Filings & 10K Form

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)

Free GTBP Stock Alerts

$3.87

-0.10 (-2.52%)

(As of 04/18/2024 ET)

Compare

Recent GT Biopharma SEC Filings

Filing Types

Ownership Filings

Time Frame

Start Date

End Date

Export to Excel

Date	Filer	Form Type
03/26/2024 4:00 PM	GT Biopharma (Filer)	Form 10-K Annual report pursuant to Section 13 or 15(d)
02/14/2024 1:46 PM	ARMISTICE CAPITAL, LLC (Filed by) GT Biopharma (Subject)	Form SC 13G/A
02/01/2024 11:15 AM	GT Biopharma (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
12/21/2023 2:30 PM	GT Biopharma (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
11/06/2023 4:21 PM	GT Biopharma (Filer)	Form DEF 14A
11/06/2023 4:23 PM	GT Biopharma (Filer)	Form DEFA14A
11/06/2023 4:25 PM	GT Biopharma (Filer)	Form DEFA14A
11/01/2023 8:00 AM	GT Biopharma (Filer)	Form 10-Q General form for quarterly reports under Section 13 or 15(d)
10/27/2023 4:23 PM	GT Biopharma (Filer)	Form PRE 14A
09/19/2023 10:56 AM	CYTOVANCE BIOLOGICS INC (Filed by) GT Biopharma (Subject)	Form SC 13G
08/22/2023 3:55 PM	GT Biopharma (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
08/15/2023 6:26 PM	GT Biopharma (Issuer) Ohri Manu (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
08/15/2023 6:29 PM	Breen Michael Martin (Reporting) GT Biopharma (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
08/07/2023 8:30 AM	GT Biopharma (Filer)	Form 10-Q General form for quarterly reports under Section 13 or 15(d)
07/05/2023 8:00 AM	GT Biopharma (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
06/21/2023 6:58 PM	CASAMENTO CHARLES J (Reporting) GT Biopharma (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
05/05/2023 4:28 PM	GT Biopharma (Filer)	Form DEFR14A
05/05/2023 4:29 PM	GT Biopharma (Filer)	Form DEFA14A
05/04/2023 6:14 PM	CASAMENTO CHARLES J (Reporting) GT Biopharma (Issuer)	Form 3 Initial statement of beneficial ownership of securities
05/04/2023 8:05 AM	GT Biopharma (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
05/01/2023 4:27 PM	GT Biopharma (Filer)	Form DEF 14A

(Data available from 1/1/2016 forward)

Related Companies and Tools

Related Companies:

SEC Filings Tools:

This page (NASDAQ:GTBP) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

GT Biopharma (GTBP) SEC Filings & 10K Form

Recent GT Biopharma SEC Filings

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info